Correlation Between Lixte Biotechnology and INVO Bioscience

Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and INVO Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and INVO Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lixte Biotechnology Holdings and INVO Bioscience, you can compare the effects of market volatilities on Lixte Biotechnology and INVO Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of INVO Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and INVO Bioscience.

Diversification Opportunities for Lixte Biotechnology and INVO Bioscience

0.15

Correlation Coefficient

Lixte Biotechnology  INVO Bioscience

Average diversification

The 3 months correlation between Lixte and INVO is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and INVO Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INVO Bioscience and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with INVO Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INVO Bioscience has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and INVO Bioscience go up and down completely randomly.

Pair Corralation between Lixte Biotechnology and INVO Bioscience

Given the investment horizon of 90 days Lixte Biotechnology is expected to generate 1.13 times less return on investment than INVO Bioscience. But when comparing it to its historical volatility, Lixte Biotechnology Holdings is 2.13 times less risky than INVO Bioscience. It trades about 0.05 of its potential returns per unit of risk. INVO Bioscience is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  108.00  in INVO Bioscience on March 14, 2024 and sell it today you would lose (33.00) from holding INVO Bioscience or give up 30.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lixte Biotechnology Holdings  vs.  INVO Bioscience

Lixte Biotechnology

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Lixte Biotechnology Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Lixte Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

INVO Bioscience

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in INVO Bioscience are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, INVO Bioscience displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Lixte Biotechnology and INVO Bioscience

The main advantage of trading using opposite Lixte Biotechnology and INVO Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, INVO Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Bioscience will offset losses from the drop in INVO Bioscience's long position.

The idea behind Lixte Biotechnology Holdings and INVO Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.